EPISODE · Aug 27, 2020 · 11 MIN
Dr Mrinalini Dey and Dr Kathrine Grøn discuss infection risk in RA
from The Rheumatology Podcast · host Oxford University Press
Dr Mrinalini Dey asks Dr Kathrine Grøn (Copenhagen, Denmark) about her recent paper, which examines infection risk in RA patients treated with abatacept, rituximab and tocilizumab. They discuss the DANBIO cohort, the differences in incidence rates between biologic-naïve patients and switchers, and also consider the results in the context of COVID-19. This paper is the Editor’s Choice for August 2020."
Embed this episode
NOW PLAYING
Dr Mrinalini Dey and Dr Kathrine Grøn discuss infection risk in RA
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.